[HTML][HTML] Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin… - Contraception, 2019 - Elsevier
Objectives To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.

K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin… - …, 2019 - europepmc.org
Objectives To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

[HTML][HTML] Segesterone Acetate/Ethinyl Estradiol 12-Month Contraceptive Vaginal System Safety Evaluation

K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin… - …, 2019 - ncbi.nlm.nih.gov
Objectives: To evaluate the safety outcomes from clinical studies of a 12-month
Contraceptive Vaginal System (CVS) releasing an average of segesterone acetate (SA) 150 …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware… - 2019 - knowledgecommons.popcouncil.org
Objectives: To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

[HTML][HTML] Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware… - …, 2019 - contraceptionjournal.org
Objectives To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware… - …, 2019 - utsouthwestern.elsevierpure.com
Objectives: To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.

K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin… - …, 2019 - escholarship.org
ObjectivesTo evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

K Gemzell-Danielsson, R Sitruk-Ware… - …, 2019 - ohiostate.elsevierpure.com
Objectives: To evaluate safety outcomes from clinical studies of a 12-month contraceptive
vaginal system (CVS) releasing an average of segesterone acetate (SA) 150 mcg and …

[PDF][PDF] Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety

K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin - Contraception, 2019 - academia.edu
Kristina Gemzell-Danielsson a,⁎, Regine Sitruk-Ware b, Mitchell D. Creinin c, Michael
Thomas d, Kurt T. Barnhart e, George Creasy b, Heather Sussman b, Mohcine Alami b, Anne …